NIMI
EXAS

Natixis Investment Managers International’s Exact Sciences EXAS Stock Holding History

Natixis Investment Managers International’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$134K Buy
2,382
+527
+28% +$32.8K 0.01% 163
2024
Q3 		$126K Sell
1,855
-468
-20% -$26.4K 0.01% 168
2024
Q2 		$98.1K Buy
2,323
+591
+34% +$32.5K 0.01% 181
2024
Q1 		$120K Buy
1,732
+430
+33% +$27.2K 0.01% 168
2023
Q4 		$96.3K Hold
1,302
– – 0.01% 199
2023
Q3 		$88.8K Sell
1,302
-85
-6% -$7.21K 0.01% 202
2023
Q2 		$130K Sell
1,387
-86
-6% -$6.71K 0.01% 160
2023
Q1 		$99.9K Sell
1,473
-225
-13% -$14.5K 0.01% 201
2022
Q4 		$84.1K Hold
1,698
– – 0.01% 208
2022
Q3 		$55K Hold
1,698
– – ﹤0.01% 218
2022
Q2 		$66K Sell
1,698
-537
-24% -$28.7K ﹤0.01% 466
2022
Q1 		$156K Buy
2,235
+1,222
+121% +$89.3K ﹤0.01% 447
2021
Q4 		$78K Buy
+1,013
New +$89.4K ﹤0.01% 208

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Investment Managers International's EXAS Position: Q4 2024 in Review

Natixis Investment Managers International increased its Exact Sciences (EXAS) stake by 28% in Q4 2024, buying an estimated $32.8K and bringing the position to 2,382 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #163.

Natixis Investment Managers International first reported a position in EXAS in Q4 2021 and has held it in 13 quarters since. The position peaked at $156K in Q1 2022. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Natixis Investment Managers International held 2,382 shares of Exact Sciences worth $134K as of Q4 2024.
  • Natixis Investment Managers International bought 527 Exact Sciences shares in Q4 2024, an estimated $32.8K.
  • Exact Sciences made up 0.01% of Natixis Investment Managers International's portfolio in Q4 2024, its #163 holding.
  • Natixis Investment Managers International first reported a position in Exact Sciences in Q4 2021 and has held it in 13 quarters since.
  • Natixis Investment Managers International's Exact Sciences position peaked at $156K in Q1 2022.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Natixis Investment Managers International's 13F filing for Q4 2024, filed 13 Feb 2025.